Intervention

GRT-R918, samRNA-SpikeOmicron-N-TCE11

ClinicalTrials.gov intervention label

Clinical trials1

Recruiting0

Common conditions2

Lead sponsors shown1

Clinical trials

1 shown

Study of Self-Amplifying Messenger Ribonucleic Acid (samRNA) Vaccines Against COVID-19 in Healthy Adults and People Living With Human Immunodeficiency Virus (HIV)NCT05435027 · 2022-02-28

COMPLETED

Common conditions

COVID-191 SARS-CoV-21

Leading sponsors

Gritstone bio, Inc.1

Trial status mix

COMPLETED1

Phase mix

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.